Patiromer Completed Phase 4 Trials for Hyperkalemia / End Stage Renal Disease (ESRD) Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03781089Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients